After years of struggle, patients with diabetes have won major victories for access to affordable insulin, but the fight is not over.
US pharmaceutical company Eli Lilly and Co recently announced a roughly $200 million expansion of its manufacturing site in ...
About the Phase 3 DIAMOND Program of OCS-01 in Diabetic Macular Edema ...
The "Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The biopharmaceuticals contract ...